OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
December 16, 2024
Pharmaceutical Technology sits down with Christian Dunne from ChargePoint Technology to discuss the key processing equipment trends in the bio/pharma industry.
December 05, 2024
As the field of bioanalytical testing evolves, it is important for drug developers to stay at the forefront of the advancements to ensure they remain competitive.
December 04, 2024
With its new offering, Lonza can tailor services to support smart capsule companies with its bi-layer capsule manufacturing technology.
November 23, 2024
The Thousand Oaks, Calif., cell therapy manufacturing facility now houses new production suites, updated development labs, and more after expansion.
November 22, 2024
The company has expanded its early and late phase analytical capabilities by including GMP cell-based potency assays at its sites in Cambridge, UK, and San Diego, Calif.
November 21, 2024
Located in German, Italy, and Lithuania, the new European facilities will specialize in drug discovery and R&D services.
November 20, 2024
SEKISUI has used a £15.7 million (US$20.7 million) investment to expand its clinical-grade drug substance manufacturing at its UK site.
November 12, 2024
Ascend is partnering with EW Healthcare Partners to expand capabilities in the United States.
November 04, 2024
The complexities of tech transfer may be overcome by data-driven approaches, digital tools, and effective communication.
October 30, 2024
The company will be expanding its quality control testing capabilities at its San Diego, Calif. biologics development and manufacturing site.